Suchergebnisse - (Subject:"Siltuximab")

PubPharm (11)

1

Siltuximab and hematologic malignancies. A focus in non Hodgkin lymphoma

enthalten in: Expert opinion on investigational drugs | 2017

von Ferrario, A. | Merli, M. | Basilico, C. | +2

2

Renal Toxicities of Novel Agents Used for Treatment of Multiple Myeloma

enthalten in: Clinical journal of the American Society of Nephrology : CJASN | 2017

von Wanchoo, R. | Abudayyeh, A. | Doshi, M. | +5

3

Monoclonal antibodies - A new era in the treatment of multiple myeloma

enthalten in: Blood reviews | 2016

von Jelinek, T. | Hajek, R.

4

Strategy for the treatment of multiple myeloma utilizing monoclonal antibodies : A new era begins

enthalten in: Leukemia & lymphoma | 2016

von Magarotto, V. | Salvini, M. | Bonello, F. | +2

5

Siltuximab : A Review in Idiopathic (Human Herpesvirus-8-Negative) Multicentric Castleman Disease

enthalten in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy | 2015

von Lyseng-Williamson, K.

6

Clinical development of siltuximab

enthalten in: Current oncology reports | 2015

von Davis, C. | Shah, K. | Lechowicz, M.

7

FDA approval : siltuximab for the treatment of patients with multicentric Castleman disease

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2015

von Deisseroth, A. | Ko, C. | Nie, L. | +11

CommentIn: Clin Cancer Res. 2015 Oct 15;21(20):4740. - PMID 26473194

8

Siltuximab (Sylvant) for treatment of multicentric castleman's disease

enthalten in: The Medical letter on drugs and therapeutics | 2015

9

Siltuximab (CNTO 328) : a promising option for human malignancies

enthalten in: Drug design, development and therapy | 2015

von Chen, R. | Chen, B.

10

Interleukin-6 : an angiogenic target in solid tumours

enthalten in: Critical reviews in oncology/hematology | 2014

von Middleton, K. | Jones, J. | Lwin, Z. | +1